Recent Finacing
Recent Raise
Creabilis is a clinical-stage biotechnology company developing dermatology and inflammatory therapeutics, including CT327, a topically applied TrkA kinase inhibitor using Low Systemic Exposure technology, plus CT637 and CT340.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors